Veritas Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-2,574,713
Closed -$377M 26
2019
Q1
$377M Buy
+2,574,713
New +$373M 3.39% 15
2017
Q2
Sell
-3,186,586
Closed -$761M 31
2017
Q1
$761M Buy
+3,186,586
New +$742M 6.87% 5
2016
Q3
Sell
-2,129,805
Closed -$492M 34
2016
Q2
$492M Buy
+2,129,805
New +$491M 5.41% 8

Other funds holding AGN

Veritas Asset Management's AGN Position: Q2 2019 in Review

Veritas Asset Management sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 2,574,713 shares — an estimated $377M sold.

Veritas Asset Management first reported a position in AGN in Q2 2016 and held it in 3 quarters. The position peaked at $761M in Q1 2017. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Veritas Asset Management reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Veritas Asset Management sold 2,574,713 Allergan plc shares in Q2 2019, an estimated $377M.
  • Veritas Asset Management first reported a position in Allergan plc in Q2 2016 and held it in 3 quarters.
  • Veritas Asset Management's Allergan plc position peaked at $761M in Q1 2017.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Veritas Asset Management's 13F filing for Q2 2019, filed 8 Aug 2019.